ResMed Balance Sheet
NYSE: RMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ResMed financial position
At the end of fiscal 2026, ResMed reported total assets of $8.97 billion, up 9.7% from a year earlier against total liabilities of $2.38 billion. Shareholders' equity stood at $6.59 billion, or 73.4% of assets. The company held $1.47 billion in cash and equivalents against $659.4 million of debt, a net cash position of $809.9 million.
The current ratio (current assets divided by current liabilities) was 3.10, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.10.
Summary generated from market data by MetaCap's automated system. Methodology
ResMed balance sheet (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 | FY 20192019-06-30 | FY 20182018-06-30 | FY 20172017-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.47B | 1.21B | 238.36M | 227.89M | 273.71M | 295.28M | 463.16M | 147.13M | 188.70M | 821.93M |
| Receivables | 1.04B | 939.49M | 837.27M | 704.91M | 575.95M | 614.29M | 474.64M | 528.48M | 483.68M | 450.53M |
| Inventory | 945.80M | 927.71M | 822.25M | 998.01M | 743.91M | 457.03M | 416.92M | 349.64M | 268.70M | 268.32M |
| Total Current Assets | 4.32B | 3.51B | 2.36B | 2.37B | 1.93B | 1.57B | 1.52B | 1.15B | 1.07B | 1.64B |
| Property, Plant & Equipment | 581.83M | 550.79M | 548.02M | 537.86M | 498.18M | 463.49M | 417.33M | 387.46M | 386.55M | 394.24M |
| Goodwill | 2.91B | 3.05B | 2.84B | 2.77B | 1.94B | 1.93B | 1.89B | 1.86B | 1.07B | 1.06B |
| Intangible Assets | 452.74M | 464.86M | 485.90M | 552.34M | 345.94M | 392.58M | 448.17M | 521.95M | 215.18M | 261.80M |
| Total Assets | 8.97B | 8.17B | 6.87B | 6.75B | 5.10B | 4.73B | 4.59B | 4.11B | 3.06B | 3.47B |
| Accounts Payable | 308.92M | 278.16M | 237.73M | 150.76M | 159.25M | 138.01M | 135.79M | 115.72M | 92.72M | 92.76M |
| Short-Term Debt | 259.95M | 9.90M | 9.90M | 9.90M | 9.92M | 12.00M | 11.99M | 11.99M | 11.47M | — |
| Total Current Liabilities | 1.40B | 1.02B | 910.65M | 758.53M | 689.30M | 911.77M | 602.76M | 555.99M | 511.25M | 360.13M |
| Long-Term Debt | 399.42M | 658.39M | 697.31M | 1.43B | 765.33M | 643.35M | 1.16B | 1.26B | 269.99M | 1.08B |
| Total Liabilities | 2.38B | 2.21B | 2.01B | 2.62B | 1.74B | 1.84B | 2.09B | 2.04B | 1.00B | 1.51B |
| Shareholders' Equity | 6.59B | 5.97B | 4.86B | 4.13B | 3.36B | 2.89B | 2.50B | 2.07B | 2.06B | 1.96B |
| Retained Earnings | 7.26B | 6.08B | 4.99B | 4.25B | 3.61B | 3.08B | 2.83B | 2.44B | 2.43B | 2.32B |
| Total Debt | 659.37M | 668.29M | 707.21M | 1.44B | 775.24M | 655.35M | 1.18B | 1.27B | 281.45M | 1.08B |
| Net Cash (Debt) | 809.87M | 541.16M | -468.85M | -1.21B | -501.53M | -360.07M | -712.96M | -1.12B | -92.75M | -256.68M |
| Shares Outstanding | 144.24M | 146.39M | 146.90M | 147.06M | 146.41M | 145.65M | 144.89M | 143.65M | 142.68M | 142.17M |
This table shows 10 annual periods of ResMed's balance sheet, from FY 2026 back to FY 2017, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow RMD's reporting calendar. What is a balance sheet?